Publication: Platelet RNA signatures for the detection of cancer
Open/View Files
Date
2017
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer US
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Sol, Nik, and Thomas Wurdinger. 2017. “Platelet RNA signatures for the detection of cancer.” Cancer Metastasis Reviews 36 (2): 263-272. doi:10.1007/s10555-017-9674-0. http://dx.doi.org/10.1007/s10555-017-9674-0.
Research Data
Abstract
Platelets are equipped with RNA processing machineries, such as pre-mRNA splicing, pre-miRNA processing, and mRNA translation. Since platelets are devoid of a nucleus, most RNA transcripts in platelets are derived from megakaryocytes during thrombocytogenesis. However, platelets can also ingest RNA molecules during circulation and/or interaction with other cell types. Since platelets were first described by Bizzozero in 1881, their well-established role in hemostasis and thrombosis has been intensively studied. However, in the past decades, the list of biological processes in which platelets play an important role keeps expanding. In this review, we discuss how platelet RNA biomarker signatures can be altered in the presence of cancer.
Description
Other Available Sources
Keywords
Platelets, Transcriptome, mRNA, Splicing, Tumor-educated platelets, Liquid biopsy, Biomarkers
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service